Report Detail
Global Non-prescription Drugs Market Insights and Forecast to 2026
- RnM4139280 |
- 17 August, 2020 |
- Global |
- 150 Pages |
- QYResearch |
- Pharma & Healthcare
Non-prescription Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Non-prescription Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Non-prescription Drugs market is segmented into
Brand Drugs
Generic Drug
Segment by Application, the Non-prescription Drugs market is segmented into
Hospital
Clinic
Other
Regional and Country-level Analysis
The Non-prescription Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Non-prescription Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Non-prescription Drugs Market Share Analysis
Non-prescription Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Non-prescription Drugs business, the date to enter into the Non-prescription Drugs market, Non-prescription Drugs product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Takeda
Boehringer Ingelheim
Takeda
1 Study Coverage
- 1.1 Non-prescription Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Non-prescription Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Non-prescription Drugs Market Size Growth Rate by Type
- 1.4.2 Brand Drugs
- 1.4.3 Generic Drug
- 1.5 Market by Application
- 1.5.1 Global Non-prescription Drugs Market Size Growth Rate by Application
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Non-prescription Drugs Market Size, Estimates and Forecasts
- 2.1.1 Global Non-prescription Drugs Revenue 2015-2026
- 2.1.2 Global Non-prescription Drugs Sales 2015-2026
- 2.2 Global Non-prescription Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Non-prescription Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Non-prescription Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Non-prescription Drugs Competitor Landscape by Players
- 3.1 Non-prescription Drugs Sales by Manufacturers
- 3.1.1 Non-prescription Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 Non-prescription Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Non-prescription Drugs Revenue by Manufacturers
- 3.2.1 Non-prescription Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 Non-prescription Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Non-prescription Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Non-prescription Drugs Revenue in 2019
- 3.2.5 Global Non-prescription Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Non-prescription Drugs Price by Manufacturers
- 3.4 Non-prescription Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Non-prescription Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Non-prescription Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Non-prescription Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Non-prescription Drugs Market Size by Type (2015-2020)
- 4.1.1 Global Non-prescription Drugs Sales by Type (2015-2020)
- 4.1.2 Global Non-prescription Drugs Revenue by Type (2015-2020)
- 4.1.3 Non-prescription Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Non-prescription Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Non-prescription Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Non-prescription Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 Non-prescription Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Non-prescription Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Non-prescription Drugs Market Size by Application (2015-2020)
- 5.1.1 Global Non-prescription Drugs Sales by Application (2015-2020)
- 5.1.2 Global Non-prescription Drugs Revenue by Application (2015-2020)
- 5.1.3 Non-prescription Drugs Price by Application (2015-2020)
- 5.2 Non-prescription Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Non-prescription Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Non-prescription Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Non-prescription Drugs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Non-prescription Drugs by Country
- 6.1.1 North America Non-prescription Drugs Sales by Country
- 6.1.2 North America Non-prescription Drugs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Non-prescription Drugs Market Facts & Figures by Type
- 6.3 North America Non-prescription Drugs Market Facts & Figures by Application
7 Europe
- 7.1 Europe Non-prescription Drugs by Country
- 7.1.1 Europe Non-prescription Drugs Sales by Country
- 7.1.2 Europe Non-prescription Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Non-prescription Drugs Market Facts & Figures by Type
- 7.3 Europe Non-prescription Drugs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Non-prescription Drugs by Region
- 8.1.1 Asia Pacific Non-prescription Drugs Sales by Region
- 8.1.2 Asia Pacific Non-prescription Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Non-prescription Drugs Market Facts & Figures by Type
- 8.3 Asia Pacific Non-prescription Drugs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Non-prescription Drugs by Country
- 9.1.1 Latin America Non-prescription Drugs Sales by Country
- 9.1.2 Latin America Non-prescription Drugs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Non-prescription Drugs Market Facts & Figures by Type
- 9.3 Central & South America Non-prescription Drugs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Non-prescription Drugs by Country
- 10.1.1 Middle East and Africa Non-prescription Drugs Sales by Country
- 10.1.2 Middle East and Africa Non-prescription Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Non-prescription Drugs Market Facts & Figures by Type
- 10.3 Middle East and Africa Non-prescription Drugs Market Facts & Figures by Application
11 Company Profiles
- 11.1 Pfizer
- 11.1.1 Pfizer Corporation Information
- 11.1.2 Pfizer Description and Business Overview
- 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Pfizer Non-prescription Drugs Products Offered
- 11.1.5 Pfizer Related Developments
- 11.2 Roche
- 11.2.1 Roche Corporation Information
- 11.2.2 Roche Description and Business Overview
- 11.2.3 Roche Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Roche Non-prescription Drugs Products Offered
- 11.2.5 Roche Related Developments
- 11.3 Sanofi
- 11.3.1 Sanofi Corporation Information
- 11.3.2 Sanofi Description and Business Overview
- 11.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Sanofi Non-prescription Drugs Products Offered
- 11.3.5 Sanofi Related Developments
- 11.4 Johnson & Johnson
- 11.4.1 Johnson & Johnson Corporation Information
- 11.4.2 Johnson & Johnson Description and Business Overview
- 11.4.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Johnson & Johnson Non-prescription Drugs Products Offered
- 11.4.5 Johnson & Johnson Related Developments
- 11.5 Merck & Co. (MSD)
- 11.5.1 Merck & Co. (MSD) Corporation Information
- 11.5.2 Merck & Co. (MSD) Description and Business Overview
- 11.5.3 Merck & Co. (MSD) Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Merck & Co. (MSD) Non-prescription Drugs Products Offered
- 11.5.5 Merck & Co. (MSD) Related Developments
- 11.6 Novartis
- 11.6.1 Novartis Corporation Information
- 11.6.2 Novartis Description and Business Overview
- 11.6.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Novartis Non-prescription Drugs Products Offered
- 11.6.5 Novartis Related Developments
- 11.7 AbbVie
- 11.7.1 AbbVie Corporation Information
- 11.7.2 AbbVie Description and Business Overview
- 11.7.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 AbbVie Non-prescription Drugs Products Offered
- 11.7.5 AbbVie Related Developments
- 11.8 Gilead Sciences
- 11.8.1 Gilead Sciences Corporation Information
- 11.8.2 Gilead Sciences Description and Business Overview
- 11.8.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Gilead Sciences Non-prescription Drugs Products Offered
- 11.8.5 Gilead Sciences Related Developments
- 11.9 GlaxoSmithKline (GSK)
- 11.9.1 GlaxoSmithKline (GSK) Corporation Information
- 11.9.2 GlaxoSmithKline (GSK) Description and Business Overview
- 11.9.3 GlaxoSmithKline (GSK) Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 GlaxoSmithKline (GSK) Non-prescription Drugs Products Offered
- 11.9.5 GlaxoSmithKline (GSK) Related Developments
- 11.10 Amgen
- 11.10.1 Amgen Corporation Information
- 11.10.2 Amgen Description and Business Overview
- 11.10.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Amgen Non-prescription Drugs Products Offered
- 11.10.5 Amgen Related Developments
- 11.1 Pfizer
- 11.1.1 Pfizer Corporation Information
- 11.1.2 Pfizer Description and Business Overview
- 11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Pfizer Non-prescription Drugs Products Offered
- 11.1.5 Pfizer Related Developments
- 11.12 Bristol-Myers Squibb
- 11.12.1 Bristol-Myers Squibb Corporation Information
- 11.12.2 Bristol-Myers Squibb Description and Business Overview
- 11.12.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Bristol-Myers Squibb Products Offered
- 11.12.5 Bristol-Myers Squibb Related Developments
- 11.13 Eli Lilly
- 11.13.1 Eli Lilly Corporation Information
- 11.13.2 Eli Lilly Description and Business Overview
- 11.13.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Eli Lilly Products Offered
- 11.13.5 Eli Lilly Related Developments
- 11.14 Teva
- 11.14.1 Teva Corporation Information
- 11.14.2 Teva Description and Business Overview
- 11.14.3 Teva Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 Teva Products Offered
- 11.14.5 Teva Related Developments
- 11.15 Bayer
- 11.15.1 Bayer Corporation Information
- 11.15.2 Bayer Description and Business Overview
- 11.15.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Bayer Products Offered
- 11.15.5 Bayer Related Developments
- 11.16 Novo Nordisk
- 11.16.1 Novo Nordisk Corporation Information
- 11.16.2 Novo Nordisk Description and Business Overview
- 11.16.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 Novo Nordisk Products Offered
- 11.16.5 Novo Nordisk Related Developments
- 11.17 Allergan
- 11.17.1 Allergan Corporation Information
- 11.17.2 Allergan Description and Business Overview
- 11.17.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
- 11.17.4 Allergan Products Offered
- 11.17.5 Allergan Related Developments
- 11.18 Takeda
- 11.18.1 Takeda Corporation Information
- 11.18.2 Takeda Description and Business Overview
- 11.18.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
- 11.18.4 Takeda Products Offered
- 11.18.5 Takeda Related Developments
- 11.19 Boehringer Ingelheim
- 11.19.1 Boehringer Ingelheim Corporation Information
- 11.19.2 Boehringer Ingelheim Description and Business Overview
- 11.19.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
- 11.19.4 Boehringer Ingelheim Products Offered
- 11.19.5 Boehringer Ingelheim Related Developments
- 11.20 Takeda
- 11.20.1 Takeda Corporation Information
- 11.20.2 Takeda Description and Business Overview
- 11.20.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
- 11.20.4 Takeda Products Offered
- 11.20.5 Takeda Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Non-prescription Drugs Market Estimates and Projections by Region
- 12.1.1 Global Non-prescription Drugs Sales Forecast by Regions 2021-2026
- 12.1.2 Global Non-prescription Drugs Revenue Forecast by Regions 2021-2026
- 12.2 North America Non-prescription Drugs Market Size Forecast (2021-2026)
- 12.2.1 North America: Non-prescription Drugs Sales Forecast (2021-2026)
- 12.2.2 North America: Non-prescription Drugs Revenue Forecast (2021-2026)
- 12.2.3 North America: Non-prescription Drugs Market Size Forecast by Country (2021-2026)
- 12.3 Europe Non-prescription Drugs Market Size Forecast (2021-2026)
- 12.3.1 Europe: Non-prescription Drugs Sales Forecast (2021-2026)
- 12.3.2 Europe: Non-prescription Drugs Revenue Forecast (2021-2026)
- 12.3.3 Europe: Non-prescription Drugs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Non-prescription Drugs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Non-prescription Drugs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Non-prescription Drugs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Non-prescription Drugs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Non-prescription Drugs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Non-prescription Drugs Sales Forecast (2021-2026)
- 12.5.2 Latin America: Non-prescription Drugs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Non-prescription Drugs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Non-prescription Drugs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Non-prescription Drugs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Non-prescription Drugs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Non-prescription Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Non-prescription Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Non-prescription Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Non-prescription Drugs. Industry analysis & Market Report on Non-prescription Drugs is a syndicated market report, published as Global Non-prescription Drugs Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Non-prescription Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
